The CRI Irvington Postdoctoral Fellowship supports promising young scientists worldwide in cancer immunology. Fellows receive dedicated mentorship and funding to pursue innovative basic, translational, or clinical cancer research projects, accelerating discoveries in immune-based therapiesaacr.org. This prestigious fellowship develops the next generation of immunotherapy leaders by providing both financial support and professional development opportunities.
Eligibility Criteria:
-
Open to early-career researchers (holding a PhD, MD, or equivalent) in any country, conducting immuno-oncology research under a sponsor’s mentorship
-
Applicant must have less than 5 years of postdoctoral training at the time of application
-
Sponsor must be an established immunology or cancer researcher at a nonprofit institution
-
No citizenship restrictions; research may be carried out at any accredited academic or research center worldwide
Funding Details:
-
Award: USD 175,500 total over 3 years (USD 59,000, USD 61,000, USD 63,000 annually)
-
Allowance: USD 1,500 per year for research supplies or travel
-
Benefits: Potential opportunity for loan repayment for physician-scientists
-
Start of fellowship: July 1, 2026 (for the current cycle)
Deadline:
-
Application deadline: March 16, 2026 (full proposal)
-
Notification: May 2026 (funding decisions announced)
-
Fellowship term: Begins July 1, 2026, for a three-year period
Where to go for further information:
-
Program details and application: CRI Irvington Fellowship page.